Digital Lifestyle Intervention Tools May Help in NAFLD
Product development should factor in the unique, complex needs of patients with NAFLD, the authors say.
Source: medscape.com
📰 Junping Shi News
Junping Shi News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Junping Shi. Real-time updates on events, politics, business and more.
Ascletis Announces Dosing of the First Patient in Phase II Clinical Trial of THRβ Agonist ASC41 for 52-Week Treatment of Liver Biopsy-Proven NASH
-- ASC41 is ranking first in China and third in the world in terms of clinical progress as a thyroid hormone receptor β (THRβ) agonist drug candidate for...
Source: prnewswire.com